Who Paid My Doc
Lutonix BTK Trial Cl000501
Research payments
$290,637
Through program year 2023, $290,637 in research payments was reported against Lutonix BTK Trial Cl000501, across 108 payments.
- Paid by (largest first)
- Bard Peripheral Vascular, Inc.; C. R. Bard, Inc. & Subsidiaries
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $5,555 | 1 |
| 2022 | Research | $2,582 | 3 |
| 2021 | Research | $48,963 | 27 |
| 2020 | Research | $109,548 | 38 |
| 2019 | Research | $123,989 | 39 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Beasley Miami, FL Named on 7 payments
- Jeffrey Goldstein Springfield, IL Named on 6 payments
- Vincent Varghese Newark, DE Named on 4 payments
- Nelson Bernardo Washington, DC Named on 3 payments
- Gary Ansel Columbus, OH Named on 3 payments
- John Rundback Astoria, NY Named on 3 payments
- Fakhir Elmasri Lakeland, FL Named on 2 payments
- Peter Soukas Brighton, MA Named on 2 payments
- John Phillips Columbus, OH Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.